Delivery Order SPE2DR25D2209-SPE2DR26FD6MS
- Not listed
- The Defense Logistics Agency awarded a $2,014.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 17, 2025. This non-set-aside award was issued on December 16, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $13,532.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. The award, issued on December 15, 2025, is a non-set-aside, competitively awarded contract with an ultimate completion date of December 16, 2025. This delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $10,441.43 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with completion scheduled for December 11, 2025. This non-competitive, firm fixed-price delivery order was issued under a competitive procurement process and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $4,677.35 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 11, 2025, with a completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract was executed on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a $2,673.56 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 5, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,843.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order was not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, valued at $3,532.04. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract specifies an ultimate completion date of December 15, 2025, and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a ceiling value of $50,714.52. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award utilizes no set-aside designation and represents a...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6MSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,607.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count unit) with a completion date of December 17, 2025. This non-competitive delivery order, awarded on December 16, 2025, utilizes firm fixed-price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The contract was awarded on a non-set-aside basis, reflecting the vendor's demonstrated capability to meet federal procurement requirements through open competition across multiple therapeutic domains and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/15/25 |